Comparison of the Risk of Severe Complications of Urinary Tract Infections (UTI) Between Patients With Type 2 Diabetes Exposed to Dapagliflozin and Those Exposed to Other Antidiabetic Treatments

First published 15/01/2016

Last updated 02/07/2024

EU PAS number:

EUPAS12113

Study

Finalised

Documents

Study protocol

Initial protocol

DAPA UTI_final_23June2014_redacted

English (1.16 MB - PDF) View document

Updated protocol

DAPA UTI_Protocol_Revisions 28Feb2017_redacted

First published: 22/02/2024

English (1.28 MB - PDF) View document

Study results

0304030_Dapa UTI Final Report_Final_9Nov2020_Abstract_Redacted

English (190.87 KB - PDF) View document

Study report

Other information

Publications

Study publications

Secondary tabs